HSA Approval

Apo-Sertraline 50mg Capsule

Approval Number

SIN13315P

Drug Name

Product Name

Apo-Sertraline 50mg Capsule

Approval Date

July 16, 2007

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

N06AB06

ATC Item Name

sertraline

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

Apotex Inc.

Active Ingredients

Ingredient Name

Sertraline (equivalent to Sertraline Hydrochloride 56mg)

Strength

50mg

Drug MonographSertraline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Apo-Sertraline 50mg Capsule - HSA Approval | MedPath

AI-Powered Research

Premium Access

Apo-Sertraline 50mg Capsule

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal